Numeric Investors’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Numeric Investors’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	$1.11M	Buy	+75,900	New	+$1.07M	0.01%	729
2017 Q2	–	Sell	-39,800	Closed	-$588K	–	1229
2017 Q1	$588K	Buy	39,800 +8,900	+29%	+$144K	0.01%	755
2016 Q4	$500K	Buy	+30,900	New	+$560K	﹤0.01%	831
2015 Q4	–	Sell	-28,300	Closed	-$561K	–	1197
2015 Q3	$561K	Buy	+28,300	New	+$894K	0.01%	673
2015 Q1	–	Sell	-13,100	Closed	-$169K	–	1113
2014 Q4	$169K	Buy	+13,100	New	+$164K	﹤0.01%	797

Other funds holding HZNP

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

BGIM

Brandywine Global Investment Management Philadelphia, Pennsylvania $14.9B AUM 20.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Numeric Investors's HZNP Position: Q4 2017 in Review

Numeric Investors opened a new position in Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2017: 75,900 shares worth $1.11M. The stake represents 0.01% of the portfolio and ranks #729 among its holdings. This is a return to the name: Numeric Investors previously reported a position in HZNP as recently as Q1 2017.

Numeric Investors first reported a position in HZNP in Q4 2014 and has held it in 5 quarters since. 183 funds tracked by Wall St. Rank hold HZNP as of Q4 2017.

Numeric Investors held 75,900 shares of Horizon Therapeutics Public Limited Company Ordinary Shares worth $1.11M as of Q4 2017.
Horizon Therapeutics Public Limited Company Ordinary Shares was a new Numeric Investors position in Q4 2017.
Horizon Therapeutics Public Limited Company Ordinary Shares made up 0.01% of Numeric Investors's portfolio in Q4 2017, its #729 holding.
Numeric Investors first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2014 and has held it in 5 quarters since.
183 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2017.

Based on Numeric Investors's 13F filing for Q4 2017, filed 14 Feb 2018.